PinnedPublished inAWS TipUltimate Guide to Deploying a Dockerized Python Django Application on AWS for Scalable DeploymentDeploying a Python Django application using AWS services ensures high availability, scalability, and reliability. This guide will provide a…Jun 25, 2024Jun 25, 2024
The Life We Try to Escape — and the One We Inevitably RebuildA take on the architecture of change, the desire to flee, and the quiet things we can never fully leave behind.Apr 2Apr 2
The Art (and Pain) of Generating Invoice Numbers That ScaleThere’s something strangely humbling about a problem that looks trivial on the surface but slowly morphs into an existential crisis at 3 AM…Feb 5Feb 5
Why I’m Saying Goodbye to Hustle Culture in 2025The end of the year has always been a time to pause, take stock of the months gone by, and think about what’s to come. Many of us use this…Dec 31, 2024Dec 31, 2024
My Top 3 Picks of 2024: Stories, Games, and BooksHere’s a roundup of my Top 3 Recommendations for Videogames, Books, Movies, TV Shows, and Comic Books from 2024. Some are new, some are old…Dec 25, 2024Dec 25, 2024
Leadership for Engineers: How to Lead Without a TitleLeadership doesn’t come with a badge. It’s not a shiny title on LinkedIn or an extra seat at the conference table. For engineers…Dec 13, 2024Dec 13, 2024
The Trouble With Being Born: A Dive into Cioran’s Existential MirrorExistence is a joke we didn’t ask to hear, a punchline delivered before we even understood the setup. In The Trouble With Being Born, Emil…Dec 12, 2024Dec 12, 2024
The Joy of Research as a HobbyWhen asked about my hobbies, I often find myself defaulting to the typical answers — reading, traveling, coding. Yet, there’s one passion…Oct 29, 2024Oct 29, 2024
Published inGoPenAIThe Simulation HypothesisAs I sit here, surrounded by the hum of machines and the glow of screens, I am reminded of the eerie feeling that we’re living in a…Sep 30, 2024A response icon1Sep 30, 2024A response icon1
FDA Approves New Schizophrenia Treatment, Offering New Hope for MillionsIn a groundbreaking development, the Food and Drug Administration (FDA) has approved Cobenfy, a novel treatment for schizophrenia, a…Sep 30, 2024Sep 30, 2024
